These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38506333)

  • 41. Factors Influencing Breast Milk Antibody Titers during the Coronavirus Disease 2019 Pandemic: An Observational Study.
    Hochmayr C; Winkler I; Hammerl M; Höller A; Huber E; Urbanek M; Kiechl-Kohlendorfer U; Griesmaier E; Posod A
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase in SARS-CoV-2 RBD-Specific IgA and IgG Antibodies in Human Milk From Lactating Women Following the COVID-19 Booster Vaccination.
    Henle AM
    J Hum Lact; 2023 Feb; 39(1):51-58. PubMed ID: 36398916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
    Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
    Front Immunol; 2021; 12():793191. PubMed ID: 34975897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.
    LaCourse SM; Wetzler EA; Aurelio MC; Escudero JN; Selke SS; Greninger AL; Goecker EA; Barnes SR; Arnould IS; Pérez-Osorio AC; Richardson BA; Kachikis A; Englund JA; Drake AL
    J Infect Dis; 2024 Jun; 229(6):1728-1739. PubMed ID: 38128542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.
    Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E
    J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contributions of vaccination and natural infection to the production of neutralizing antibodies against the SARS-CoV-2 prototype strain and variants.
    Xie H; Zhang J; Bai S; Lv M; Li J; Chen W; Suo L; Chen M; Zhao W; Zhou S; Wang J; Zhang A; Ma J; Wang F; Yan L; Li D; Wu J
    Int J Infect Dis; 2024 Jul; 144():107060. PubMed ID: 38670482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination.
    Baird JK; Jensen SM; Urba WJ; Fox BA; Baird JR
    J Hum Lact; 2021 Aug; 37(3):492-498. PubMed ID: 34297643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination.
    Stafford LS; Valcarce V; Henry M; Neu J; Parker L; Mueller M; Vicuna V; Gowen T; Cato E; Kosik I; Yewdell JW; Atkinson M; Cacho N; Li N; Larkin J
    J Perinatol; 2023 Jun; 43(6):775-781. PubMed ID: 36631564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and Efficacy of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines During Lactation.
    Shook LL; Edlow AG
    Obstet Gynecol; 2023 Mar; 141(3):483-491. PubMed ID: 36649326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing.
    Li J; Li J; Dai S; Dang L; Wang L; Cao L; Chen X; Wang Y; Ge M; Liu W; Song Q; Xu W; Ma L
    Front Immunol; 2023; 14():1269665. PubMed ID: 37828994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19.
    Pace RM; Williams JE; Järvinen KM; Belfort MB; Pace CDW; Lackey KA; Gogel AC; Nguyen-Contant P; Kanagaiah P; Fitzgerald T; Ferri R; Young B; Rosen-Carole C; Diaz N; Meehan CL; Caffé B; Sangster MY; Topham D; McGuire MA; Seppo A; McGuire MK
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies Against SARS-CoV-2 in Human Breast Milk After Vaccination: A Systematic Review and Meta-Analysis.
    Whited N; Cervantes J
    Breastfeed Med; 2022 Jun; 17(6):475-483. PubMed ID: 35325550
    [No Abstract]   [Full Text] [Related]  

  • 55. SARS-CoV-2-specific antibodies and neutralization capacity in breast milk following infection vs vaccination.
    Leung HYH; Leung BW; Gil MM; Rolle V; Moungmaithong S; Wang CC; Poon LC
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):425-427. PubMed ID: 35653222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
    Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
    Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination.
    Cagigi A; Yu M; Österberg B; Svensson J; Falck-Jones S; Vangeti S; Åhlberg E; Azizmohammadi L; Warnqvist A; Falck-Jones R; Gubisch PC; Ödemis M; Ghafoor F; Eisele M; Lenart K; Bell M; Johansson N; Albert J; Sälde J; Pettie DD; Murphy MP; Carter L; King NP; Ols S; Normark J; Ahlm C; Forsell MN; Färnert A; Loré K; Smed-Sörensen A
    JCI Insight; 2021 Nov; 6(22):. PubMed ID: 34665783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study.
    Juncker HG; Romijn M; Loth VN; Caniels TG; de Groot CJM; Pajkrt D; van Gils MJ; van Goudoever JB; van Keulen BJ
    J Hum Lact; 2021 Aug; 37(3):485-491. PubMed ID: 34308720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up.
    Matusali G; Sberna G; Meschi S; Gramigna G; Colavita F; Lapa D; Francalancia M; Bettini A; Capobianchi MR; Puro V; Castilletti C; Vaia F; Bordi L
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
    Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.